DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Business Affairs Homepage

NYU offers full-tuition scholarships to new, current med students Only offer of its kind in the top 10 U.S. med schools

Tech giants sign on to interoperability pledge Amazon, Google, IBM, Microsoft, Oracle, and Salesforce agree to common interest

Scottish radiologist shortage looming 'We are on red alert – there is absolutely no doubt about this'

In Korea and Italy, imaging OEMs face accusations of anti-competitive actions Are unfair tactics being used to hurt non-OEM equipment servicers?

GE Healthcare joins AdvaMed Access to global thought leadership and policy area expertise

Forces driving healthcare M&A activity Understanding why consolidation is going to continue

Boston Scientific to buy VENITI for $160 million Price may rise pending FDA approval of Vici Venous Stent

Sotera Health's Nordion closes sale of medical isotopes business to BWX Technologies About 150 employees will be transferred in the deal

FDA clears Aidoc AI solution for triaging head CT scans Flags acute intracranial hemorrhage cases by focusing on abnormal regions

Henry Ford Health System and GM enter "Direct to Employer" healthcare contract A first-of-its-kind arrangement for both organizations

FDA, Philips reach agreement on AED manufacturing over quality control issues

by Thomas Dworetzky , Contributing Reporter
The FDA has reached a deal with Philips North America (also known as Philips Medical Systems and Philips Healthcare) over quality control issues with its automatic defibrillator manufacturing process – announced with a consent decree of permanent injunction entered by U.S. district judge Denise J. Casper.

The October 31 decree, with limited exceptions, “prohibits Philips and those individually named from manufacturing, processing, packing, holding or distributing devices made by the Emergency Care and Resuscitation (ECR) business unit at their Andover, Massachusetts, and Bothell, Washington, facilities until they comply with the Federal Food, Drug and Cosmetic Act (FD&C Act) and FDA regulations, in addition to other requirements,” according to an FDA release.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

“We are committed to delivering high quality, innovative products and solutions, and we take this matter very seriously,” Chief Business Leader Connected Care & Health Informatics at Royal Philips Carla Kriwet said in a statement when news of the deal was first announced in mid-October.

She emphasized that the company was “fully prepared” to satisfy the decree and hoped to start defibrillator production again in 2018.

“Over the last years, we have made significant investments in our Quality Management System, with the change in our company-wide quality leadership and the launch of new standards and initiatives across all our businesses and markets,” she said, adding that the company would continue “to further enhance our quality management throughout Philips.”

The decree also enjoined two company officers – Kriwet and Ojas Buch, PCMS VP of quality and regulatory assurance, according to the announcement.

“AEDs are lifesaving tools and are designed to be used by the general public or professionals in an emergency,” said Melinda Plaisier, associate commissioner for regulatory affairs at the FDA, advising that “Philips distributed adulterated products that put people at risk.”

The complaint holds that the company was at fault because its AEDs and Q-CPR Meters were made “in violation of current good manufacturing practice (CGMP) requirements under the FD&C Act based on noncompliance with quality system (QS) regulations.”

In addition, Philips didn't set up “ adequate processes” to fix the issues, says the government.

The decree will suspend operations, with few exceptions, in those two locations until the company “completes corrective actions, including hiring a qualified third-party CGMP expert” to make sure it is up to quality requirements – and reports back to the FDA that it is OK to open the facilities again.

In mid-October, when the company had agreed to the terms, Kriwet told HCB News, "Following FDA inspections at the Andover and Bothell facilities from 2009 to 2015, FDA investigators made observations regarding Philips' compliance with the Good Manufacturing Practices and medical device reporting requirements of the Food, Drug and Cosmetic Act, with a focus on how Philips addressed issues of its defibrillators."

To address these concerns the company has put steps in place to restructure its quality control function, she noted, and put in new leadership, retrain personnel and introduce culture change initiatives.

"Philips takes this matter extremely seriously," said Kriwet. "The company is committed to fulfilling the terms of the Consent Decree, and we have already taken actions since 2015 to address this."

Business Affairs Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.